These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9638368)

  • 1. Negative regulation of T cell activation.
    Saito T
    Curr Opin Immunol; 1998 Jun; 10(3):313-21. PubMed ID: 9638368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.
    Guntermann C; Alexander DR
    J Immunol; 2002 May; 168(9):4420-9. PubMed ID: 11970985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of T cell inactivation by CTLA-4.
    Lee KM; Chuang E; Griffin M; Khattri R; Hong DK; Zhang W; Straus D; Samelson LE; Thompson CB; Bluestone JA
    Science; 1998 Dec; 282(5397):2263-6. PubMed ID: 9856951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion to target cells is disrupted by the killer cell inhibitory receptor.
    Burshtyn DN; Shin J; Stebbins C; Long EO
    Curr Biol; 2000 Jun; 10(13):777-80. PubMed ID: 10898979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy.
    Nel AE; Slaughter N
    J Allergy Clin Immunol; 2002 Jun; 109(6):901-15. PubMed ID: 12063516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.
    Chambers CA; Kang J; Wu Y; Held W; Raulet DH; Allison JP
    Blood; 2002 Jun; 99(12):4509-16. PubMed ID: 12036882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
    Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
    Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More negative feedback?
    Coyle AJ; Gutierrez-Ramos JC
    Nat Immunol; 2003 Jul; 4(7):647-8. PubMed ID: 12830142
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.
    Gajewski TF; Fallarino F; Fields PE; Rivas F; Alegre ML
    J Immunol; 2001 Mar; 166(6):3900-7. PubMed ID: 11238634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.
    Baroja ML; Luxenberg D; Chau T; Ling V; Strathdee CA; Carreno BM; Madrenas J
    J Immunol; 2000 Jan; 164(1):49-55. PubMed ID: 10604992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune inhibitory receptors.
    Ravetch JV; Lanier LL
    Science; 2000 Oct; 290(5489):84-9. PubMed ID: 11021804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.
    Chikuma S; Imboden JB; Bluestone JA
    J Exp Med; 2003 Jan; 197(1):129-35. PubMed ID: 12515820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?
    Linsley PS
    J Exp Med; 1995 Aug; 182(2):289-92. PubMed ID: 7543133
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of CTLA-4 as an immune attenuator.
    Thompson CB; Allison JP
    Immunity; 1997 Oct; 7(4):445-50. PubMed ID: 9354465
    [No Abstract]   [Full Text] [Related]  

  • 18. CTLA-4, a negative regulator of T-lymphocyte activation.
    Waterhouse P; Marengère LE; Mittrücker HW; Mak TW
    Immunol Rev; 1996 Oct; 153():183-207. PubMed ID: 9010724
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors.
    Saito T; Yamasaki S
    Immunol Rev; 2003 Apr; 192():143-60. PubMed ID: 12670402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.
    Cinek T; Sadra A; Imboden JB
    J Immunol; 2000 Jan; 164(1):5-8. PubMed ID: 10604984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.